A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis

NCT07150988 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: HSK44459 dose level 1
DRUG: HSK44459 dose level 2
DRUG: placebo

Sponsor

Haisco Pharmaceutical Group Co., Ltd.